CIK 0000318306 · Non-accelerated filer<br>Smaller reporting company
ABEONA THERAPEUTICS INC.
Sign in to watch- Ticker
- ABEO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 830221517
- Phone
- 646-813-4701
- Business address
- 6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, OH, 44103
- Former names
- PLASMATECH BIOPHARMACEUTICALS INC, ACCESS PHARMACEUTICALS INC, CHEMEX PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $296,397
- in 5 filings
Net −$296,397. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Seshadri Vishwas −$101K Chief Executive Officer sold 2% of stake
- Alvino Mark −$88K Director sold 19% of stake
- Vazzano Joseph Walter −$47K Chief Financial Officer sold 2% of stake
- O'Malley Brendan M. −$35K SVP, Chief Legal Officer sold 2% of stake
- Vasanthavada Madhav −$25K Chief Commercial Officer sold 2% of stake
Reading 57 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-03-29 | Thiel Carsten Chief Executive Officer | Grant or award · Stock option (right to buy) | +87,500 | 87,500 | ||
| 2018-03-29 | Thiel Carsten Chief Executive Officer | Grant or award · Stock option (right to buy) | +262,500 | 262,500 | ||
| 2017-12-14 | Howell Stephen B. Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2017-12-14 | THOMPSON STEPHEN B Sr VP Finance | Grant or award · Stock option (right to buy) | +6,250 | 6,250 | ||
| 2017-12-14 | THOMPSON STEPHEN B Sr VP Finance | Grant or award · Stock option (right to buy) | +18,750 | 18,750 | ||
| 2017-12-14 | Alvino Mark Director | Grant or award · Stock option (right to buy) | +30,000 | 30,000 | ||
| 2017-12-14 | Wider Todd Director | Grant or award · Stock option (right to buy) | +30,000 | 30,000 | ||
| 2017-12-14 | Miller Timothy J President & CEO | Grant or award · Stock option (right to buy) | +22,500 | 22,500 | ||
| 2017-12-14 | Miller Timothy J President & CEO | Grant or award · Stock option (right to buy) | +67,500 | 67,500 | ||
| 2017-12-14 | Jeffrey B Davis COO | Grant or award · Stock option (right to buy) | +20,000 | 20,000 | ||
| 2017-12-14 | Jeffrey B Davis COO | Grant or award · Stock option (right to buy) | +60,000 | 60,000 | ||
| 2017-12-14 | Rouhandeh Steven H Executive Chairman | Grant or award · Srock option (right to buy) | +30,000 | 30,000 | ||
| 2017-12-14 | Rouhandeh Steven H Executive Chairman | Grant or award · Stock option (right to buy) | +90,000 | 90,000 | ||
| 2016-12-13 | Howell Stephen B. Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2016-12-13 | THOMPSON STEPHEN B VP Finance-Chief Acctg Officer | Grant or award · Stock option right to buy) | +6,250 | 6,250 | ||
| 2016-12-13 | THOMPSON STEPHEN B VP Finance-Chief Acctg Officer | Grant or award · Stock option (right to buy) | +18,750 | 25,000 | ||
| 2016-12-13 | Wider Todd Director | Grant or award · Stock option (right to buy) | +50,000 | 50,000 | ||
| 2016-12-13 | Alvino Mark Director | Grant or award · Stock option (right to buy) | +50,000 | 50,000 | ||
| 2016-12-13 | Ahn Mark J Director | Grant or award · Stock option (right to buy) | +150,000 | 150,000 | ||
| 2016-12-13 | Jeffrey B Davis Chief Operating Officer | Grant or award · Stock option (right to buy) | +37,500 | 37,500 |
Page 20 of 23 · 443 trades